![Hepatorenal syndrome / Syndromes / Hypertension / Pulmonary hypertension / Nitric oxide / Heart failure / Health / Chemistry / Medicine Hepatorenal syndrome / Syndromes / Hypertension / Pulmonary hypertension / Nitric oxide / Heart failure / Health / Chemistry / Medicine](https://www.pdfsearch.io/img/5dcd116a96b4f592514fab58de4fd461.jpg)
| Document Date: 2012-05-29 13:53:20 Open Document File Size: 73,63 KBShare Result on Facebook
City Madison / Melbourne / Hampton / / Company Ikaria Inc. / Ikaria Australia Pty Ltd / / Continent North America / / Country Puerto Rico / France / Japan / United States / Canada / Australia / Mexico / Spain / South Korea / Ireland / / Event FDA Phase / M&A / / Facility Port Allen / / IndustryTerm drug-device combination product / drug product / treatment of Hepatorenal Syndrome / treatment of hypoxic respiratory failure / manufacturing facilities / treatment for Hepatorenal Syndrome / / MedicalCondition bronchopulmonary dysplasia / advanced liver cirrhosis / pulmonary arterial hypertension / chronic obstructive pulmonary disease / pulmonary hypertension / subsequent congestive heart failure / kidney failure / renal failure / hypoxic respiratory failure / acute myocardial infarction / / MedicalTreatment innovative therapies / liver transplant / / Organization Therapeutic Goods Administration / FDA / / Person Daniel Tassé / Lorna Meldrum / / Position General Manager / Chairman and CEO / / Product INOMAX / LUCASSIN® (terlipressin) / LUCASSIN / France / / ProvinceOrState New Jersey / Wisconsin / / Technology drug-delivery system / / URL www.ikaria.com / /
SocialTag |